MYBORTE
BORTEZOMIB
Public price
4,77 MAD
Active substance
BORTEZOMIB
Laboratory
AXESS PHARMA
What is this medicine?
MYBORTE contains BORTEZOMIB. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
BORTEZOMIB, POUDRE POUR SOLUTION INJECTABLE, 3,5 MG, BOITE DE 1 FLACON
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Laboratory
AXESS PHARMA
Hospital price
4,50 MAD
Strength
3,5 MG
Form
POUDRE POUR SOLUTION INJECTABLE
Presentation
BOITE DE 1 FLACON
Commercial status
Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 4,77 MAD
Available presentations and strengths
Medicines with the same active substance
VELCADE
1 MG · BOITE DE 1 FLACON DE 10 ML
1,37 MAD
CYTOMIB
3,5 MG · BOITE DE 1 FLACON DE 10 ML
3,31 MAD
BORT SPAL 2
2 MG · BOITE DE 1 FLACON
3,38 MAD
VEELBORE
3,5 MG · BOITE DE 1
3,65 MAD
BORT SPAL
3.5 MG · BOITE DE 1 FLACON
5,62 MAD
BORTEA
3.5 MG · BOITE D'UN FLACON
5,62 MAD
VELCADE
3,5 MG · BOITE DE 1 FLACON DE 10 ML
5,86 MAD
VELCADE 1 MG
1 MG · Flacon de 5 ml
1.367,00 MAD
CYTOMIB 3.5 MG
3.5 MG · Boite de 1 flacon de 10 ML
3.306,00 MAD
BORT SPAL 2 MG
2 MG · Boite de 1 flacon
3.381,00 MAD
BORT SPAL 2 MG
2 MG · Poudre pour solution injectable
3.381,00 MAD
VEELBORE 3.5 MG
3.5 MG · Boite de un flacon de 8 ML
3.650,00 MAD